TY - JOUR AU - Friedman, S. L. PY - 2018 DA - 2018// TI - Mechanisms of NAFLD development and therapeutic strategies JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0104-9 DO - 10.1038/s41591-018-0104-9 ID - Friedman2018 ER - TY - JOUR AU - Dyson, J. PY - 2014 DA - 2014// TI - Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2013.08.011 DO - 10.1016/j.jhep.2013.08.011 ID - Dyson2014 ER - TY - JOUR AU - Mittal, S. PY - 2016 DA - 2016// TI - Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease JO - Clin Gastroenterol Hepatol VL - 14 UR - https://doi.org/10.1016/j.cgh.2015.07.019 DO - 10.1016/j.cgh.2015.07.019 ID - Mittal2016 ER - TY - JOUR AU - Wong, R. J. PY - 2015 DA - 2015// TI - Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States JO - Gastroenterology VL - 148 UR - https://doi.org/10.1053/j.gastro.2014.11.039 DO - 10.1053/j.gastro.2014.11.039 ID - Wong2015 ER - TY - JOUR AU - Koehler, E. M. PY - 2012 DA - 2012// TI - Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study JO - J Hepatol VL - 57 UR - https://doi.org/10.1016/j.jhep.2012.07.028 DO - 10.1016/j.jhep.2012.07.028 ID - Koehler2012 ER - TY - JOUR AU - Söderberg, C. PY - 2010 DA - 2010// TI - Decreased survival of subjects with elevated liver function tests during a 28-year follow-up JO - Hepatology VL - 51 UR - https://doi.org/10.1002/hep.23314 DO - 10.1002/hep.23314 ID - Söderberg2010 ER - TY - JOUR AU - Younossi, Z. M. PY - 2016 DA - 2016// TI - Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes JO - Hepatology VL - 64 UR - https://doi.org/10.1002/hep.28431 DO - 10.1002/hep.28431 ID - Younossi2016 ER - TY - STD TI - Nunez, D.J., et al., Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. Am J Physiol Gastrointest Liver Physiol. 2019;316(3):G372–86. ID - ref8 ER - TY - JOUR AU - McPherson, S. PY - 2015 DA - 2015// TI - Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management JO - J Hepatol VL - 62 UR - https://doi.org/10.1016/j.jhep.2014.11.034 DO - 10.1016/j.jhep.2014.11.034 ID - McPherson2015 ER - TY - JOUR AU - Alexander, M. PY - 2018 DA - 2018// TI - Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease JO - BMC Med VL - 16 UR - https://doi.org/10.1186/s12916-018-1103-x DO - 10.1186/s12916-018-1103-x ID - Alexander2018 ER - TY - JOUR AU - Vargas-Santos, A. B. PY - 2018 DA - 2018// TI - Association of Chronic Kidney Disease with Allopurinol use in gout treatment JO - JAMA Intern Med VL - 178 UR - https://doi.org/10.1001/jamainternmed.2018.4463 DO - 10.1001/jamainternmed.2018.4463 ID - Vargas-Santos2018 ER - TY - JOUR AU - Kringos, D. PY - 2013 DA - 2013// TI - The strength of primary care in Europe: an international comparative study JO - Br J Gen Pract VL - 63 UR - https://doi.org/10.3399/bjgp13X674422 DO - 10.3399/bjgp13X674422 ID - Kringos2013 ER - TY - JOUR AU - Gini, R. PY - 2013 DA - 2013// TI - Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey JO - BMC Public Health VL - 13 UR - https://doi.org/10.1186/1471-2458-13-15 DO - 10.1186/1471-2458-13-15 ID - Gini2013 ER - TY - JOUR AU - Vlug, A. E. PY - 1999 DA - 1999// TI - Postmarketing surveillance based on electronic patient records: the IPCI project JO - Methods Inf Med VL - 38 ID - Vlug1999 ER - TY - JOUR AU - Garcia-Gil Mdel, M. PY - 2011 DA - 2011// TI - Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP) JO - Inform Prim Care VL - 19 ID - Garcia-Gil Mdel2011 ER - TY - JOUR AU - Blak, B. T. PY - 2011 DA - 2011// TI - Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates JO - Inform Prim Care VL - 19 ID - Blak2011 ER - TY - JOUR AU - Filippi, A. PY - 2005 DA - 2005// TI - Computerized general practice databases provide quick and cost-effective information on the prevalence of angina pectoris JO - Ital Heart J VL - 6 ID - Filippi2005 ER - TY - STD TI - IQVIA. The Health Improvement Network. 18th March, 2019]; Available from: https://www.iqvia.com/locations/uk-and-ireland/thin-hes-data. Accessed 30 Apr 2019. UR - https://www.iqvia.com/locations/uk-and-ireland/thin-hes-data ID - ref18 ER - TY - JOUR AU - Alazawi, W. PY - 2014 DA - 2014// TI - Ethnicity and the diagnosis gap in liver disease: a population-based study JO - Br J Gen Pract VL - 64 UR - https://doi.org/10.3399/bjgp14X682273 DO - 10.3399/bjgp14X682273 ID - Alazawi2014 ER - TY - JOUR AU - Patel, P. J. PY - 2018 DA - 2018// TI - Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis JO - Intern Med J VL - 48 UR - https://doi.org/10.1111/imj.13667 DO - 10.1111/imj.13667 ID - Patel2018 ER - TY - JOUR AU - Standing, H. C. PY - 2018 DA - 2018// TI - GPs' experiences and perceptions of early detection of liver disease: a qualitative study in primary care JO - Br J Gen Pract VL - 68 UR - https://doi.org/10.3399/bjgp18X699377 DO - 10.3399/bjgp18X699377 ID - Standing2018 ER - TY - JOUR AU - Singh, S. PY - 2015 DA - 2015// TI - Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies JO - Clin Gastroenterol Hepatol VL - 13 UR - https://doi.org/10.1016/j.cgh.2014.04.014 DO - 10.1016/j.cgh.2014.04.014 ID - Singh2015 ER - TY - JOUR AU - Boursier, J. PY - 2016 DA - 2016// TI - Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease JO - J Hepatol VL - 65 UR - https://doi.org/10.1016/j.jhep.2016.04.023 DO - 10.1016/j.jhep.2016.04.023 ID - Boursier2016 ER - TY - JOUR AU - Ekstedt, M. PY - 2015 DA - 2015// TI - Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up JO - Hepatology VL - 61 UR - https://doi.org/10.1002/hep.27368 DO - 10.1002/hep.27368 ID - Ekstedt2015 ER - TY - JOUR AU - Younossi, Z. M. PY - 2017 DA - 2017// TI - Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease JO - Hepatol Commun VL - 1 UR - https://doi.org/10.1002/hep4.1054 DO - 10.1002/hep4.1054 ID - Younossi2017 ER - TY - STD TI - De Silva S, et al. Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of south Asian descent. Frontline Gastroenterol. 2018;9(2):115–21. ID - ref26 ER - TY - JOUR AU - Chalasani, N. PY - 2018 DA - 2018// TI - The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases JO - Hepatology VL - 67 UR - https://doi.org/10.1002/hep.29367 DO - 10.1002/hep.29367 ID - Chalasani2018 ER - TY - JOUR PY - 2016 DA - 2016// TI - EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease JO - J Hepatol VL - 64 UR - https://doi.org/10.1016/j.jhep.2015.11.004 DO - 10.1016/j.jhep.2015.11.004 ID - ref28 ER - TY - JOUR AU - Newsome, P. h. i. l. i. p. N. AU - Cramb, R. o. b. AU - Davison, S. u. z. a. n. n. e. M. AU - Dillon, J. o. h. n. F. AU - Foulerton, M. a. r. k. AU - Godfrey, E. d. m. u. n. d. M. AU - Hall, R. i. c. h. a. r. d. AU - Harrower, U. l. r. i. k. e. AU - Hudson, M. a. r. k. AU - Langford, A. n. d. r. e. w. AU - Mackie, A. n. n. e. AU - Mitchell-Thain, R. o. b. e. r. t. AU - Sennett, K. a. r. e. n. AU - Sheron, N. i. c. h. o. l. a. s. C. AU - Verne, J. u. l. i. a. AU - Walmsley, M. a. r. t. i. n. e. AU - Yeoman, A. n. d. r. e. w. PY - 2017 DA - 2017// TI - Guidelines on the management of abnormal liver blood tests JO - Gut VL - 67 UR - https://doi.org/10.1136/gutjnl-2017-314924 DO - 10.1136/gutjnl-2017-314924 ID - Newsome2017 ER - TY - STD TI - Hassan MM, et al. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma. Gastroenterology. 2015;149(1):119–29. ID - ref30 ER -